Curodont is a new product which could provide a cure for early caries through enamel regeneration. The idea, developed by Swiss company Credentis together with the University of Leeds, is to stop caries early and initiate self-repair by mimicking the processes of natural tooth development.

Curodont contains a self-assembling peptide that induces de novo hydroxyapatite crystallisation and inhibits demineralisation. When applied to the white spot it diffuses through the pores of the hypermineralised plate and forms a 3D matrix within the early carious lesion around which new enamel grows. It is the only product to reverse active initial caries. Curodont offers a patient friendly, pain free, non-invasive, tooth preserving treatment.

Credentis plan to launch Curodont in the UK in 2013. It will be supplied only to dental professionals and will not be released to the general public.

Further information can be found at www.credentis.com.